0000000000545598

AUTHOR

B Becker

showing 3 related works from this author

Measurement of the Proton-Air Cross Section at root s=57 TeV with the Pierre Auger Observatory

2012

We report a measurement of the proton-air cross section for particle production at the center-of-mass energy per nucleon of 57 TeV. This is derived from the distribution of the depths of shower maxima observed with the Pierre Auger Observatory: systematic uncertainties are studied in detail. Analyzing the tail of the distribution of the shower maxima, a proton-air cross section of [505±22(stat)-36+28(syst)]mb is found. © 2012 American Physical Society.

Physics and Astronomy (all)Astrophysics::High Energy Astrophysical PhenomenaSettore FIS/01 - Fisica SperimentaleAstrophysics::Instrumentation and Methods for AstrophysicsHigh Energy Physics::ExperimentNuclear Experiment
researchProduct

ALICE: Physics performance report, volume II

2006

ALICE is a general-purpose heavy-ion experiment designed to study the physics of strongly interacting matter and the quark-gluon plasma in nucleus-nucleus collisions at the LHC. It currently involves more than 900 physicists and senior engineers, from both the nuclear and high-energy physics sectors, from over 90 institutions in about 30 countries. The ALICE detector is designed to cope with the highest particle multiplicities above those anticipated for Pb-Pb collisions (dN(ch)/dy up to 8000) and it will be operational at the start-up of the LHC. In addition to heavy systems, the ALICE Collaboration will study collisions of lower-mass ions, which are a means of varying the energy density, …

PhysicsParticle physicsNuclear and High Energy PhysicsLarge Hadron Collider010308 nuclear & particles physicsPhysicsDetectorMonte Carlo methodObservable7. Clean energy01 natural sciencesParticle identificationNuclear physics0103 physical sciencesALICE (propellant)010306 general physicsNuclear ExperimentALICE; physics; performance; detector; CERN; QGP; LHCEvent (particle physics)Event reconstruction
researchProduct

Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according t…

2012

CONTEXT: In the absence of an effective vaccine, serogroup B Neisseria meningitidis (MenB) remains a major cause of invasive disease in early childhood in developed countries. OBJECTIVE: To determine the immunogenicity and reactogenicity of a multicomponent MenB vaccine (4CMenB) and routine infant vaccines when given either concomitantly or separately. DESIGN, SETTING, AND PARTICIPANTS: Phase 2b, multicenter, open-label, parallel-group, randomized controlled study of 1885 infants enrolled at age 2 months from August 2008 to July 2010 in Europe. INTERVENTION: Participants were randomized 2:2:1:1 to receive (1) 4CMenB at 2, 4, and 6 months with routine vaccines (7-valent pneumococcal and comb…

MalePediatricsmedicine.medical_specialtyContext (language use)Meningococcal VaccinesMeningococcal vaccineNeisseria meningitidisSerum Bactericidal Antibody AssayDrug Administration SchedulemedicineHumansImmunization ScheduleVaccinesVaccines SyntheticReactogenicityTetanusbusiness.industryDiphtheriaInfantGeneral Medicinemedicine.diseasePoliomyelitisVaccinationMeningococcal InfectionsAntibody FormationFemalePertactinbusiness
researchProduct